These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17726260)

  • 21. Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity.
    Moretti RM; Montagnani Marelli M; Mai S; Limonta P
    Int J Oncol; 2008 Aug; 33(2):405-13. PubMed ID: 18636163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of PLZF in melanoma progression.
    Felicetti F; Bottero L; Felli N; Mattia G; Labbaye C; Alvino E; Peschle C; Colombo MP; Carè A
    Oncogene; 2004 Jun; 23(26):4567-76. PubMed ID: 15077196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
    Müller DW; Bosserhoff AK
    Oncogene; 2008 Nov; 27(52):6698-706. PubMed ID: 18679415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.
    Boregowda RK; Olabisi OO; Abushahba W; Jeong BS; Haenssen KK; Chen W; Chekmareva M; Lasfar A; Foran DJ; Goydos JS; Cohen-Solal KA
    Cancer Lett; 2014 Jun; 348(1-2):61-70. PubMed ID: 24657655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
    Kuphal S; Bosserhoff AK
    Oncogene; 2006 Jan; 25(2):248-59. PubMed ID: 16132038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IRE1α-XBP1 pathway promotes melanoma progression by regulating IL-6/STAT3 signaling.
    Chen C; Zhang X
    J Transl Med; 2017 Feb; 15(1):42. PubMed ID: 28222747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
    Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
    Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple pro-tumorigenic functions of the human minor Histocompatibility Antigen-1 (HA-1) in melanoma progression.
    Xu P; Ma J; Ma J; Zhang W; Guo S; Jian Z; Liu L; Wang G; Gao T; Zhu G; Li C
    J Dermatol Sci; 2017 Nov; 88(2):216-224. PubMed ID: 28939173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma.
    Kuphal S; Wallner S; Bosserhoff AK
    Exp Mol Pathol; 2013 Oct; 95(2):156-65. PubMed ID: 23831429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Status of RASSF1A in uveal melanocytes and melanoma cells.
    Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
    Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression.
    Braig S; Bosserhoff AK
    Oncogene; 2013 Feb; 32(7):837-48. PubMed ID: 22469980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEACAM1 enhances invasion and migration of melanocytic and melanoma cells.
    Ebrahimnejad A; Streichert T; Nollau P; Horst AK; Wagener C; Bamberger AM; Brümmer J
    Am J Pathol; 2004 Nov; 165(5):1781-7. PubMed ID: 15509546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional implication of truncated P-cadherin expression in malignant melanoma.
    Bauer R; Bosserhoff AK
    Exp Mol Pathol; 2006 Dec; 81(3):224-30. PubMed ID: 16919267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombomodulin modulates cell migration in human melanoma cell lines.
    de Oliveira Ada S; Yang L; Echevarria-Lima J; Monteiro RQ; Rezaie AR
    Melanoma Res; 2014 Feb; 24(1):11-9. PubMed ID: 24366193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion.
    Melchiori A; Mortarini R; Carlone S; Marchisio PC; Anichini A; Noonan DM; Albini A
    Exp Cell Res; 1995 Jul; 219(1):233-42. PubMed ID: 7628538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characterization of six aspartate (D) recombinant mojastin mutants (r-Moj): A second aspartate amino acid carboxyl to the RGD in r-Moj-D_ peptides is not sufficient to induce apoptosis of SK-Mel-28 cells.
    Ramos CJ; Gutierrez DA; Aranda AS; Koshlaychuk MA; Carrillo DA; Medrano R; McBride TD; U A; Medina SM; Lombardo MC; Lucena SE; Sanchez EE; Soto JG
    Toxicon; 2016 Aug; 118():36-42. PubMed ID: 27105671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha5 expression in U251 glioma cell line.
    Kita D; Takino T; Nakada M; Takahashi T; Yamashita J; Sato H
    Cancer Res; 2001 Nov; 61(21):7985-91. PubMed ID: 11691823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.
    Bhattacharya A; Schmitz U; Wolkenhauer O; Schönherr M; Raatz Y; Kunz M
    Oncogene; 2013 Jun; 32(26):3175-83. PubMed ID: 22847610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
    Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
    Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.